Cargando…
Co occurrance of Macular Telangiectasia type 2 with hemorrhagic polypoidal choroidal vasculopathy and response to anti-vascular endothelial growth factor
We report the case of a 57-year-old female patient who presented with defective vision in the right eye due to large hemorrhagic pigment epithelial detachment with subretinal hemorrhage near the arcades with scattered retinal pigment epithelium (RPE) alteration at the macula and minimal vitreous hem...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433040/ https://www.ncbi.nlm.nih.gov/pubmed/37602155 http://dx.doi.org/10.4103/ojo.ojo_281_22 |
_version_ | 1785091562524377088 |
---|---|
author | Shah, Shreyas Manayath, George J. Gajula, Shruthi Narendran, Venkatapathy |
author_facet | Shah, Shreyas Manayath, George J. Gajula, Shruthi Narendran, Venkatapathy |
author_sort | Shah, Shreyas |
collection | PubMed |
description | We report the case of a 57-year-old female patient who presented with defective vision in the right eye due to large hemorrhagic pigment epithelial detachment with subretinal hemorrhage near the arcades with scattered retinal pigment epithelium (RPE) alteration at the macula and minimal vitreous hemorrhage inferiorly. The left eye showed right angle perifoveal dipping venule with RPE alteration temporal to the fovea, intraretinal RPE stellate plaque at the macula area. Multimodal imaging features including color fundus photo, red-free photograph, optical coherence tomography (OCT), enhanced depth imaging OCT, fundus fluorescein angiography, indocyanine green angiography, and OCT angiography were studied along with treatment response. One eye showed features of macular telangiectasia Type 2 (MacTel 2) with polypoidal choroidal vasculopathy (PCV) (hemorrhagic type) and the other eye showed features of MacTel 2 with pachychoroid pigment epitheliopathy. This report highlights the hitherto undescribed co-occurrence of MacTel 2 with bilateral pachychoroid and with unilateral hemorrhagic PCV in one eye and its favorable outcome with anti-vascular endothelial growth factor therapy. |
format | Online Article Text |
id | pubmed-10433040 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-104330402023-08-18 Co occurrance of Macular Telangiectasia type 2 with hemorrhagic polypoidal choroidal vasculopathy and response to anti-vascular endothelial growth factor Shah, Shreyas Manayath, George J. Gajula, Shruthi Narendran, Venkatapathy Oman J Ophthalmol Case Report We report the case of a 57-year-old female patient who presented with defective vision in the right eye due to large hemorrhagic pigment epithelial detachment with subretinal hemorrhage near the arcades with scattered retinal pigment epithelium (RPE) alteration at the macula and minimal vitreous hemorrhage inferiorly. The left eye showed right angle perifoveal dipping venule with RPE alteration temporal to the fovea, intraretinal RPE stellate plaque at the macula area. Multimodal imaging features including color fundus photo, red-free photograph, optical coherence tomography (OCT), enhanced depth imaging OCT, fundus fluorescein angiography, indocyanine green angiography, and OCT angiography were studied along with treatment response. One eye showed features of macular telangiectasia Type 2 (MacTel 2) with polypoidal choroidal vasculopathy (PCV) (hemorrhagic type) and the other eye showed features of MacTel 2 with pachychoroid pigment epitheliopathy. This report highlights the hitherto undescribed co-occurrence of MacTel 2 with bilateral pachychoroid and with unilateral hemorrhagic PCV in one eye and its favorable outcome with anti-vascular endothelial growth factor therapy. Wolters Kluwer - Medknow 2023-06-27 /pmc/articles/PMC10433040/ /pubmed/37602155 http://dx.doi.org/10.4103/ojo.ojo_281_22 Text en Copyright: © 2023 Oman Ophthalmic Society https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Case Report Shah, Shreyas Manayath, George J. Gajula, Shruthi Narendran, Venkatapathy Co occurrance of Macular Telangiectasia type 2 with hemorrhagic polypoidal choroidal vasculopathy and response to anti-vascular endothelial growth factor |
title | Co occurrance of Macular Telangiectasia type 2 with hemorrhagic polypoidal choroidal vasculopathy and response to anti-vascular endothelial growth factor |
title_full | Co occurrance of Macular Telangiectasia type 2 with hemorrhagic polypoidal choroidal vasculopathy and response to anti-vascular endothelial growth factor |
title_fullStr | Co occurrance of Macular Telangiectasia type 2 with hemorrhagic polypoidal choroidal vasculopathy and response to anti-vascular endothelial growth factor |
title_full_unstemmed | Co occurrance of Macular Telangiectasia type 2 with hemorrhagic polypoidal choroidal vasculopathy and response to anti-vascular endothelial growth factor |
title_short | Co occurrance of Macular Telangiectasia type 2 with hemorrhagic polypoidal choroidal vasculopathy and response to anti-vascular endothelial growth factor |
title_sort | co occurrance of macular telangiectasia type 2 with hemorrhagic polypoidal choroidal vasculopathy and response to anti-vascular endothelial growth factor |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433040/ https://www.ncbi.nlm.nih.gov/pubmed/37602155 http://dx.doi.org/10.4103/ojo.ojo_281_22 |
work_keys_str_mv | AT shahshreyas cooccurranceofmaculartelangiectasiatype2withhemorrhagicpolypoidalchoroidalvasculopathyandresponsetoantivascularendothelialgrowthfactor AT manayathgeorgej cooccurranceofmaculartelangiectasiatype2withhemorrhagicpolypoidalchoroidalvasculopathyandresponsetoantivascularendothelialgrowthfactor AT gajulashruthi cooccurranceofmaculartelangiectasiatype2withhemorrhagicpolypoidalchoroidalvasculopathyandresponsetoantivascularendothelialgrowthfactor AT narendranvenkatapathy cooccurranceofmaculartelangiectasiatype2withhemorrhagicpolypoidalchoroidalvasculopathyandresponsetoantivascularendothelialgrowthfactor |